Hiroyuki Kirikoshi

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

Masato Yoneda, Masato Yoneda, Hironori Mawatari et al. · Digestive and Liver Disease · 2007 · 421 citations

Liver Fibrosis, Hepatology, Metabolic Associated Steatotic Liver Disease +11

Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling

Kento Imajo, Koji Fujita, Masato Yoneda et al. · Cell Metabolism · 2012 · 334 citations · Full text

Inflammation, Hepatology, Low-dose Endotoxin +12

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

Masato Yoneda, Hironori Mawatari, Koji Fujita et al. · Journal of Gastroenterology · 2007 · 291 citations

Liver Fibrosis, Immunology, Pathology +17

Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis # †

Koji Fujita, Yuichi Nozaki, Koichiro Wada et al. · Hepatology · 2009 · 238 citations

Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis

Kensuke Kubota, Hiroshi Iida, Toshio Fujisawa et al. · Gastrointestinal Endoscopy · 2007 · 138 citations

Autoimmune Disease, Clinical Factors, Immunology +11